Type 2 diabetes Flashcards

1
Q

What significant morbidity is linked to T2DM?

A
Cancer
Cirrhosis
Retinopathy
Stroke
Heart disease
Nephropathy
Foot problems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is T2DM?

A

Combination of insulin resistance allied to a failure of adequate insulin secretion
Imbalance results in T2DM
Insulin output is unable to match resistance levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the key features of T2DM disease progression

A

Hyperinsulinaemia
Insulin resistance
Hyperglycaemia

Macrovascular complications occur earlier on
Microvascular complications are observed later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why does insulin resistance occur?

A
> Genetic susceptibility
> Environmental triggers
> Two major predictors:
   - Poverty
   - Ethnicity
> Visceral fat producing adipokines
> Genetic conditions 
  - small no. with insulin receptor mutations: severe hyperinsulinaemia, associated with acanthosis nigricans and features of hyperandrogenism -> Very strong genetic predisposition - normally all family members are affected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are adipokines?

A

Cytokines secreted by the adipose tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List the adipokines

A

Leptin
Adiponectin
TNFalpha
Resistin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where are adipokines found?

A

In the visceral fat around organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is leptin?

A

An adipokine

- Tells hypothalamus about amount of stores fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is adiponectin?

A

An adipokine

- Reduced levels of free fatty acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is TNFalpha

A

An adipokine

- Associated with low-grade inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is resistin?

A

An adipokine

- Enhances hypothalmic stimulation of glucose production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What factors can affect insulin secretion?

A

> Glucotoxicity can lead to impaired beta cell function
Glucokinase defects impair insulin secretion
Pancreatic beta cell transcription factor mutations lead to reduced insulin production in response to glucose - still senses glucose levels but inadequate insulin production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is microvascular disease?

A

Complications related to smaller blood vessels (e.g. in kidney, eyes and nerves)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How can microvascular disease be prevented?

A

Reduction of glucose levels

Reducing HbA1c by 10mmol/mol results in a 20% overall risk reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which drug acts on the gut?

A

Acarbose

  • inhibits alpha glucosidase, (a small intestine brush border enzyme) and pancreatic alpha-amylase
  • reduces digestion of complex carbohydrates, minimising glucose absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which drugs acts at the muscle bed?

A

Metformin & Pioglitazone modify glucose uptake at the muscle bed

Insulin also has an impact on glucose uptake at the muscle bed

17
Q

Which drug acts on the kidney?

A

SGLT2 inhibitors

18
Q

Which drugs increase insulin secretion?

A

> Insulin
sulfonylurea -> constant insulin release
DDP-4 inhibitors -> augment insulin secretion in a glucose-dependent manner
GLP-1 receptor agonists -> augment insulin secretion in a glucose-dependent manner

19
Q

Which drugs act on the liver?

A

Reduce glucose production

> Metformin
GLP-1 receptor agonists
DPP-4 inhibitors
Insulin

20
Q

What are GLP-1 effects in humans?

A

Secreted upon the ingestion of food

> beta cell - enhances glucose-dependent insulin secretion in the pancreas
alpha cell - suppresses post-prandial glucagon secretion
liver - reduces hepatic glucose output
stomach - slows the rate of gastro emptying
brain - promotes satiety and reduces appetite

21
Q

How can GLP-1 levels be influenced?

A

Preventing breakdown by DPP-4 to increase physiological levels

Exogenous GLP-1 agonist

22
Q

What are the effects of using exogenous GLP-1 agonists?

A

Significant glucose-lowering benefit

Weight loss

23
Q

Name DPP-4 inhibitors

A
Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
Alogliptin
24
Q

Name GLP-1 receptor agonists

A
Exanatide
Liraglutide
Exenatide
Lixisenatide
Dulaglutide
25
What is the mechanism of action of SGLT2 inhibitors
Inhibits SGLT2, which reabsorbs 90% glucose in the proximal tubule of the kidney - More glucose is excreted - Plasma glucose levels drop - Weight decreases due to calorie loss NB: causes osmotic diuresis -> lowers blood pressure Can predispose to significant acidosis in patients with insufficient insulin Should NOT be used in T1DM
26
Name SGLT2 inhibitors
Dapaglifloxin Canagliflozin Empagliflozin
27
What is the first line treatment for T2DM
Lifestyle measures | Metformin or sulphonylurea (if intolerent to metformin or osmotic symptoms present)
28
What is the second line treatment for T2DM?
``` If not reaching target after 3-6 months: Check adherence Add one of: - sulphonylurea - pioglitazone - DPP-4 inhibitor - SGLT2 inhibitor ```
29
What is the third line treatment for T2DM?
``` If not reaching target after 3-6 months: Check adherence Add either an oral agent of a different class: - sulphonylurea - pioglitazone - DPP-4 inhibitor - SGLT2 inhibitor OR an injectable agent: - if BMI >30 = GLP-1 agonist - if BMI <30 = basal insulin ```